Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, May 5, 2023
[ Fri, May 05th 2023
] - WOPRAI
Thu, May 4, 2023
[ Thu, May 04th 2023
] - WOPRAI
[ Thu, May 04th 2023
] - WOPRAI
[ Thu, May 04th 2023
] - WOPRAI
[ Thu, May 04th 2023
] - WOPRAI
[ Thu, May 04th 2023
] - WOPRAI
[ Thu, May 04th 2023
] - WOPRAI
[ Thu, May 04th 2023
] - WOPRAI
[ Thu, May 04th 2023
] - WOPRAI
[ Thu, May 04th 2023
] - WOPRAI
[ Thu, May 04th 2023
] - WOPRAI
[ Thu, May 04th 2023
] - WOPRAI
[ Thu, May 04th 2023
] - WOPRAI
[ Thu, May 04th 2023
] - WOPRAI
[ Thu, May 04th 2023
] - WOPRAI
[ Thu, May 04th 2023
] - WOPRAI
[ Thu, May 04th 2023
] - WOPRAI
[ Thu, May 04th 2023
] - WOPRAI
[ Thu, May 04th 2023
] - WOPRAI
[ Thu, May 04th 2023
] - WOPRAI
[ Thu, May 04th 2023
] - WOPRAI
[ Thu, May 04th 2023
] - WOPRAI
[ Thu, May 04th 2023
] - WOPRAI
[ Thu, May 04th 2023
] - WOPRAI
[ Thu, May 04th 2023
] - WOPRAI
[ Thu, May 04th 2023
] - WOPRAI
[ Thu, May 04th 2023
] - WOPRAI
[ Thu, May 04th 2023
] - WOPRAI
[ Thu, May 04th 2023
] - WOPRAI
[ Thu, May 04th 2023
] - WOPRAI
Michael Petusky Reiterated (XRAY) at Buy with Increased Target to $51 on, May 4th, 2023
Michael Petusky of Barrington Research, Reiterated "DENTSPLY SIRONA Inc." (XRAY) at Buy with Increased Target from $43 to $51 on, May 4th, 2023.
Michael has made no other calls on XRAY in the last 4 months.
There are 3 other peers that have a rating on XRAY. Out of the 3 peers that are also analyzing XRAY, all agree with Michael's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Nathan Rich of "Goldman Sachs" Maintained at Hold with Increased Target to $39 on, Thursday, March 2nd, 2023
- Jason Bednar of "Piper Sandler" Maintained at Hold with Increased Target to $35 on, Monday, February 6th, 2023
- Brandon Vazquez of "William Blair" Upgraded from Sell to Hold on, Thursday, January 12th, 2023
